EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Electrographic flow mapping guided catheter ablation offers advantages for patients with persistent atrial fibrillation

Rita B Gagyi iD, Rohit E Bhagwandien, Sing-Chien Yap iD, Mark Hoogendijk, Sip Wijchers, Tamas Szili-Torok iD

Pacing and Clinical Electrophysiology · 2023

DOI: 10.1111/pace.14744 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pacing and Clinical Electrophysiology, 2023. Verfasst von Rita B Gagyi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Electrophysiology, Erasmus Medical Center, Rotterdam, The Netherlands. Hauptthemen laut MEDLINE: Atrial Fibrillation, Pulmonary Veins, Tachycardia, Supraventricular, Catheter Ablation. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Catheter ablation (CA) remains challenging due to suboptimal success rates in persistent atrial fibrillation (AF). Existing mapping technologies cannot reliably distinguish sources in this patient population. Recently, the novel electrographic flow (EGF) mapping system was developed using a modified Horn‐Schunk optical flow algorithm to detect and quantify patterns of electrical wavefront propagation in the atria.

Objectives

To test the hypothesis that targeted source ablation based on EGF mapping is superior to empiric AF ablation.

Methods

We included all consecutive patients undergoing EGF guided ablation for persistent AF. All patients underwent pulmonary vein isolation (PVI) and were treated with the same EAM system (CARTO). The outcome of PVI+EGF guided CA was compared with data of PVI‐only procedures (PVI‐only group) and PVI plus additional empiric adjunctive linear and substrate ablations (PVI+LINES group). 12‐months outcome as freedom from AF and atrial tachycardia/flutter (AT/AFL), procedural safety and efficiency characterized by procedure duration, fluoroscopy use, radiofrequency applications and duration, were analyzed. Both intention‐to‐treat and per protocol analysis were conducted.

Results

A total number of 70 patients (39 in PVI+EGF, 16 in PVI‐only and 15 patients in PVI+LINES group) were enrolled. Intention‐to‐treat analysis showed fewer AF recurrences in PVI+EGF as compared with the PVI‐only or PVI+LINES groups at 12 months (25.6% vs. 62.5% vs. 53.3%, p = .02). There were no differences in AT/AFL recurrence (17.9% vs. 37.5% vs. 20.0%, p = .37). Procedure times were longer in PVI+EGF group ( p < .01), and there were no differences in fluoroscopy use ( p = .67).

Conclusion

Our data suggest that patients treated with EGF‐guided CA developed fewer AF recurrences. Although the procedure times are longer, it seems to be safe and offers a more targeted, patient‐specific ablation strategy beyond PVI than adjunctive empiric lines and substrate ablation in this complex group of patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationPulmonary VeinsTachycardia, SupraventricularCatheter AblationHumansEpidermal Growth FactorTreatment OutcomeRecurrence

Stichwörter der Autor:innen

catheter ablationelectroanatomic mappingelectrographic flow mappingpersistent atrial fibrillationpulmonary vein isolationthree-dimensional mapping

Substanzen

Epidermal Growth Factor

Autor:innen und Institutionen

  • Department of Clinical Electrophysiology, Erasmus Medical Center, Rotterdam, The Netherlands.

ORCID-Profile: Rita B Gagyi, Sing-Chien Yap, Tamas Szili-Torok

Zitieren

APA

Gagyi, R. B., Bhagwandien, R. E., Yap, S. C., Hoogendijk, M., Wijchers, S., & Szili-Torok, T. (2023). Electrographic flow mapping guided catheter ablation offers advantages for patients with persistent atrial fibrillation. Pacing and Clinical Electrophysiology. https://doi.org/10.1111/pace.14744

Vancouver

Gagyi RB, Bhagwandien RE, Yap SC, Hoogendijk M, Wijchers S, Szili-Torok T. Electrographic flow mapping guided catheter ablation offers advantages for patients with persistent atrial fibrillation. Pacing and Clinical Electrophysiology. 2023. doi:10.1111/pace.14744

BibTeX
@article{Gagyi2023,
  author = {Gagyi, Rita B and Bhagwandien, Rohit E and Yap, Sing-Chien and Hoogendijk, Mark and Wijchers, Sip and Szili-Torok, Tamas},
  title = {Electrographic flow mapping guided catheter ablation offers advantages for patients with persistent atrial fibrillation},
  journal = {Pacing and Clinical Electrophysiology},
  year = {2023},
  doi = {10.1111/pace.14744}
}
Kostenlos starten →